Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Bianco and Matthew Ettleson.
Connection Strength
6.856
-
TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort. J Clin Endocrinol Metab. 2024 Nov 18; 109(12):3065-3075.
Score: 0.885
-
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism. J Clin Endocrinol Metab. 2023 11 17; 108(12):e1614-e1623.
Score: 0.826
-
Serum Thyrotropin and Triiodothyronine Levels in Levothyroxine-treated Patients. J Clin Endocrinol Metab. 2023 05 17; 108(6):e258-e266.
Score: 0.797
-
Brain Fog in Hypothyroidism: Understanding the Patient's Perspective. Endocr Pract. 2022 Mar; 28(3):257-264.
Score: 0.722
-
Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? J Clin Endocrinol Metab. 2020 09 01; 105(9).
Score: 0.661
-
Adverse Outcomes in Patients With Hypothyroidism Undergoing Bariatric Surgery: A Retrospective Study Using TriNetX. J Clin Endocrinol Metab. 2026 Feb 20; 111(3):e766-e777.
Score: 0.241
-
Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality. J Clin Endocrinol Metab. 2026 Jan 21; 111(2):561-571.
Score: 0.240
-
Measuring Hypothyroidism Disease Control Using a TSH-based "Time-in-range". J Clin Endocrinol Metab. 2026 Jan 21; 111(2):e484-e492.
Score: 0.240
-
Lower Serum Triiodothyronine Levels Constitute an Independent Risk Factor for Dyslipidemia in Levothyroxin-Treated Patients. Endocr Pract. 2026 Feb; 32(2):135-141.
Score: 0.233
-
Treatment Preferences in Patients With Hypothyroidism. J Clin Endocrinol Metab. 2025 Feb 18; 110(3):887-900.
Score: 0.225
-
The Impact of Hypothyroidism on Cardiovascular-Related Healthcare Utilization in the US Population With Diabetes. J Endocr Soc. 2024 Nov 26; 9(1):bvae204.
Score: 0.221
-
A Cross-Sectional Analysis of Cardiovascular and Bone Health Care Utilization During Treatment With Thyroid Hormone. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1143-e1150.
Score: 0.210
-
The Effects of Patient Characteristics on the Management of Subclinical Hypothyroidism: A Survey of Faculty and Trainees. Endocr Pract. 2023 Oct; 29(10):787-793.
Score: 0.202
-
Are We Restoring Thyroid Hormone Signaling in Levothyroxine-Treated Patients With Residual Symptoms of Hypothyroidism? Endocr Pract. 2023 Jul; 29(7):581-588.
Score: 0.201
-
Suboptimal Thyroid Hormone Replacement Is Associated With Worse Hospital Outcomes. J Clin Endocrinol Metab. 2022 07 14; 107(8):e3411-e3419.
Score: 0.188
-
The relevance of T3 in the management of hypothyroidism. Lancet Diabetes Endocrinol. 2022 05; 10(5):366-372.
Score: 0.183
-
Extended Absorption of Liothyronine from Poly-Zinc-Liothyronine: Results from a Phase 1, Double-Blind, Randomized, and Controlled Study in Humans. Thyroid. 2022 02; 32(2):196-205.
Score: 0.181
-
Sociodemographic Disparities in the Treatment of Hypothyroidism: NHANES 2007-2012. J Endocr Soc. 2021 Jul 01; 5(7):bvab041.
Score: 0.171
-
Use of Statins Among Patients Taking Levothyroxine: an Observational Drug Utilization Study Across Sites. J Endocr Soc. 2021 Jul 01; 5(7):bvab038.
Score: 0.171
-
Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil. J Clin Endocrinol Metab. 2024 Sep 16; 109(10):2504-2512.
Score: 0.055